Analysis of Source Material
1. Core Topic & User Question:
The article discusses the FDA‘s increased scrutiny and planned enforcement actions regarding direct-to-consumer (DTC) advertising of compounded drugs. The FDA is clarifying that compounded drugs cannot be marketed as equivalent to or interchangeable with FDA-approved drugs, even if they contain the same active ingredients. The user question this article addresses is: *What is the FDA’s current stance on the marketing of compounded medications,
Related reading